230 related articles for article (PubMed ID: 3668979)
1. Cerebrospinal fluid immunoglobulins and neuronal antibodies in neuropsychiatric systemic lupus erythematosus and related conditions.
Kelly MC; Denburg JA
J Rheumatol; 1987 Aug; 14(4):740-4. PubMed ID: 3668979
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid IgM, IgA, and IgG indexes in systemic lupus erythematosus. Their use as estimates of central nervous system disease activity.
Hirohata S; Hirose S; Miyamoto T
Arch Intern Med; 1985 Oct; 145(10):1843-6. PubMed ID: 3899036
[TBL] [Abstract][Full Text] [Related]
3. Association of cerebrospinal fluid anti-ribosomal p protein antibodies with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus.
Hirohata S; Arinuma Y; Takayama M; Yoshio T
Arthritis Res Ther; 2007; 9(3):R44. PubMed ID: 17472755
[TBL] [Abstract][Full Text] [Related]
4. Antiganglioside antibodies in cerebrospinal fluid of children with neuropsychiatric lupus erythematosus.
Chen Y; Wu F; Hou L; Ma S; He X
Chin Med J (Engl); 1997 Aug; 110(8):594-7. PubMed ID: 9594260
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric assessment of anti-neuronal antibodies in central nervous system involvement of systemic lupus erythematosus and other autoimmune diseases.
Kang EH; Shen GQ; Morris R; Metzger A; Lee EY; Lee YJ; Lee EB; Song YW
Lupus; 2008 Jan; 17(1):21-5. PubMed ID: 18089679
[TBL] [Abstract][Full Text] [Related]
6. Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus.
Isshi K; Hirohata S
Arthritis Rheum; 1998 Oct; 41(10):1819-27. PubMed ID: 9778223
[TBL] [Abstract][Full Text] [Related]
7. Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement.
Trysberg E; Blennow K; Zachrisson O; Tarkowski A
Arthritis Res Ther; 2004; 6(6):R551-6. PubMed ID: 15535833
[TBL] [Abstract][Full Text] [Related]
8. Increased intrathecal immunoglobulin synthesis of both kappa and lambda types in patients with systemic lupus erythematosus and central nervous system involvement.
Hirohata S; Miyamoto T
J Rheumatol; 1986 Aug; 13(4):715-21. PubMed ID: 3095548
[TBL] [Abstract][Full Text] [Related]
9. [Systemic lupus erythematosus and the central nervous system].
Rojas E; Orrea Solano M
Rev Alerg; 1993; 40(2):46-9. PubMed ID: 9312334
[TBL] [Abstract][Full Text] [Related]
10. Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus.
Yoshio T; Hirata D; Onda K; Nara H; Minota S
J Rheumatol; 2005 Jan; 32(1):34-9. PubMed ID: 15630721
[TBL] [Abstract][Full Text] [Related]
11. Detection of activated terminal complement (C5b-9) in cerebrospinal fluid from patients with central nervous system involvement of primary Sjogren's syndrome or systemic lupus erythematosus.
Sanders ME; Alexander EL; Koski CL; Frank MM; Joiner KA
J Immunol; 1987 Apr; 138(7):2095-9. PubMed ID: 3559203
[TBL] [Abstract][Full Text] [Related]
12. A close temporal relationship of liver disease to antiribosomal P0 protein antibodies and central nervous system disease in patients with systemic lupus erythematosus.
Yoshio T; Masuyama JI; Minota S; Kaneko N; Iwamoto M; Okazaki H; Mimori A; Takeda A; Kano S
J Rheumatol; 1998 Apr; 25(4):681-8. PubMed ID: 9558169
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus.
Bluestein HG; Williams GW; Steinberg AD
Am J Med; 1981 Feb; 70(2):240-6. PubMed ID: 7468611
[TBL] [Abstract][Full Text] [Related]
14. Systemic lupus erythematosus of the central nervous system: 2. Molecular theories and models for mental disease.
Moskowitz N
Mt Sinai J Med; 1989 Jan; 56(1):23-9. PubMed ID: 2784179
[TBL] [Abstract][Full Text] [Related]
15. Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement.
Trysberg E; Nylen K; Rosengren LE; Tarkowski A
Arthritis Rheum; 2003 Oct; 48(10):2881-7. PubMed ID: 14558094
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid interleukin-6, prostaglandin E2 and autoantibodies in patients with neuropsychiatric systemic lupus erythematosus and central nervous system infections.
Tsai CY; Wu TH; Tsai ST; Chen KH; Thajeb P; Lin WM; Yu HS; Yu CL
Scand J Rheumatol; 1994; 23(2):57-63. PubMed ID: 8165438
[TBL] [Abstract][Full Text] [Related]
17. Blood-brain barrier damage as a risk factor for corticosteroid-induced psychiatric disorders in systemic lupus erythematosus.
Nishimura K; Harigai M; Omori M; Sato E; Hara M
Psychoneuroendocrinology; 2008 Apr; 33(3):395-403. PubMed ID: 18261856
[TBL] [Abstract][Full Text] [Related]
18. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities.
Ainiala H; Hietaharju A; Dastidar P; Loukkola J; Lehtimäki T; Peltola J; Korpela M; Heinonen T; Nikkari ST
Arthritis Rheum; 2004 Mar; 50(3):858-65. PubMed ID: 15022328
[TBL] [Abstract][Full Text] [Related]
19. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
[TBL] [Abstract][Full Text] [Related]
20. Anticardiolipin antibodies in serum and cerebrospinal fluid from patients with systemic lupus erythematosus.
Martínez-Cordero E; Rivera García BE; Aguilar León DE
J Investig Allergol Clin Immunol; 1997; 7(6):596-601. PubMed ID: 9491201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
